GSE252944 AKT inhibition 11 v 6 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE252944_AKT inhibition_11_v_6_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE252944_AKT inhibition_11_v_6_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE252944_AKT inhibition_11_v_6_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE252944_AKT inhibition_11_v_6_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

high mobility group box 1 pseudogene 5

Gene

RNA, 5.8S ribosomal N1

Gene

RNA, 5.8S ribosomal N3

Gene

RNA, 5.8S ribosomal pseudogene 10

Gene

RNA, 5.8S ribosomal N2

Gene

zinc finger protein 603, pseudogene

Gene

TFAP2E antisense RNA 1

Gene

ATP binding cassette subfamily C member 13 (pseudogene)

Gene

PRRT3 antisense RNA 1

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    high mobility group box 1 pseudogene 5


  • Gene

    RNA, 5.8S ribosomal N1


  • Gene

    RNA, 5.8S ribosomal N3


  • Gene

    RNA, 5.8S ribosomal pseudogene 10


  • Gene

    RNA, 5.8S ribosomal N2


  • Gene

    zinc finger protein 603, pseudogene


  • Gene

    TFAP2E antisense RNA 1


  • Gene

    ATP binding cassette subfamily C member 13 (pseudogene)


  • Gene

    PRRT3 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.